aflatoxin b1 has been researched along with phenanthrenes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, PA; Wilson, VL | 1 |
| Groopman, JD; Kensler, TW; Knight, LP; Primiano, T; Sutter, TR | 1 |
| Stewart, JK; Tombes, RM; Zhang, L; Zhou, Q; Zuniga, MA | 1 |
| Baumgartner, KJ; Dinkova-Kostova, AT; Egner, PA; Gribble, GW; Groopman, JD; Honda, T; Kensler, TW; Liby, K; Risingsong, R; Roebuck, BD; Royce, DB; Sporn, MB; Stephenson, KK; Sundararajan, C; Williams, CR; Yates, MS; Yore, MM; Yoshizawa, H | 1 |
| David, E; Favaloro, FG; Gribble, GW; Honda, T; Honda, Y; Janosik, T; Lajoie, MJ; Roebuck, BD; Su, X; Sundararajan, C; Yoshizawa, H | 1 |
| Al-Rashid, ZF; Beri, V; Cheung, J; Rosenberry, TL; Shiomi, K; Wildman, SA | 1 |
6 other study(ies) available for aflatoxin b1 and phenanthrenes
| Article | Year |
|---|---|
Chemical carcinogen-mediated decreases in DNA 5-methylcytosine content of BALB/3T3 cells.
Topics: 5-Methylcytosine; Aflatoxin B1; Aflatoxins; Animals; Benz(a)Anthracenes; Benzo(a)pyrene; Benzopyrenes; Carcinogens; Cytosine; DNA; DNA (Cytosine-5-)-Methyltransferases; Dose-Response Relationship, Drug; Fibroblasts; In Vitro Techniques; Methylcholanthrene; Mice; Mice, Inbred BALB C; Phenanthrenes | 1984 |
cDNA cloning, expression and activity of a second human aflatoxin B1-metabolizing member of the aldo-keto reductase superfamily, AKR7A3.
Topics: Aflatoxin B1; Aldehyde Reductase; Aldo-Keto Reductases; Amino Acid Sequence; Animals; Base Sequence; Benzaldehydes; Cloning, Molecular; DNA, Complementary; Humans; Immunoblotting; Liver; Molecular Sequence Data; Multigene Family; Phenanthrenes; Rats; RNA, Messenger; Sequence Homology, Amino Acid; Tissue Distribution | 1999 |
Mixed inhibition of P450 3A4 as a chemoprotective mechanism against aflatoxin B1-induced cytotoxicity with cis-terpenones.
Topics: Aflatoxin B1; Algorithms; Anticarcinogenic Agents; Carcinogens; Cells, Cultured; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Enzyme Inhibitors; Glutathione; Humans; Hydrolysis; In Vitro Techniques; Indicators and Reagents; Ketoconazole; Kinetics; Microsomes, Liver; Phenanthrenes | 2008 |
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin.
Topics: Administration, Oral; Aflatoxin B1; Animals; Apoptosis; Cell Differentiation; Cell Proliferation; Cell Transformation, Neoplastic; Cells, Cultured; DNA Adducts; Heme Oxygenase-1; Humans; Imidazoles; Leukemia; Liver Neoplasms; Macrophages; Male; Mice; Molecular Structure; NAD(P)H Dehydrogenase (Quinone); Nitric Oxide; Nitric Oxide Synthase Type II; Oleanolic Acid; Phenanthrenes; Rats; Rats, Inbred F344; Reactive Oxygen Species | 2008 |
Tricyclic compounds containing nonenolizable cyano enones. A novel class of highly potent anti-inflammatory and cytoprotective agents.
Topics: Aflatoxin B1; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cells, Cultured; Cytoprotection; Enzyme Induction; Heme Oxygenase-1; Interferon-gamma; Liver; Liver Neoplasms, Experimental; Macrophages; Male; Mice; NAD(P)H Dehydrogenase (Quinone); Nitric Oxide Synthase Type II; Nitriles; Pentacyclic Triterpenes; Phenanthrenes; Precancerous Conditions; Rats; Stereoisomerism; Stomach; Structure-Activity Relationship | 2011 |
The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity.
Topics: Acetylcholine; Acetylcholinesterase; Aflatoxin B1; Binding Sites; Binding, Competitive; Catalysis; Catalytic Domain; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Humans; Hydrolysis; Kinetics; Models, Chemical; Phenanthrenes; Pyrans; Quinones; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2013 |